Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £26.93m
NMT Live PriceLast checked at - London Stock Exchange

Intraday Neometals Share Chart

Director / PDMR Dealings

11 Sep 2023 10:52

RNS Number : 0311M
Neometals Ltd
11 September 2023
 

11 September 2023

Neometals Ltd

("Neometals" or "the Company")

Director / PDMR Dealings

Emerging sustainable battery materials producer, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company") advises that a total of 3,884,433 performance rights (Performance Rights) have been granted to certain employees and contractors under the Company's Performance Rights Plan (PRP), as approved by shareholders on 25 November 2022.

Included within this award are 571,512 Performance Rights for Chris Reed, Chief Executive Officer, and 314,759 Performance Rights for Jason Carone, Chief Financial Officer and Company Secretary.

Each Performance Right entitles the holder to a fully paid ordinary share in the Company at no cost. The number of Performance Rights that may vest on 30 June 2026 (or 31 December 2026) will be determined by reference to the extent to which the performance conditions as measured in respect of the period ending on the relevant vesting date have been met. Any vested Performance Rights are exercisable within 12 months from the vesting date.

The updated interests of the above individuals (following issue of 3,884,433 Performance Rights pursuant to the PRP) in the share capital of the Company are as follows:

PDMR

New performance rights

Vested performance rights

Total performance rights*

Total shares (direct and indirect)

Chris Reed

571,512

1,491,079

3,042,219

7,868,589

Jason Carone

314,759

532,844

1,361,618

766,462

*Includes both vested and unvested PRP Performance Rights which remain subject to vesting conditions.

As a result of the issue of the Performance Rights to the NEDs pursuant to the Company's PRP, the Company has the following securities on issue:

· 553,307,937 fully paid ordinary shares.

· 15,221,224 performance rights issued pursuant to the terms of the PRP, comprising:

5,494,032 vested performance rights, which remain subject to exercise; and

9,727,192 unvested performance rights, which are subject to performance testing in accordance with their terms of issue.

The above figure of 553,307,937 ordinary shares on issue may be used by shareholders as the denominator for calculations when determining if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Change of Name of Nominated Adviser and Joint Broker 

 

The Company also announces that its Nominated Adviser and Joint Broker has changed its name to Cavendish Securities plc following completion of its own corporate merger."

 

Authorised on behalf of Neometals by Jason Carone, Company Secretary

 

ENDS

 

For more information, please contact:

 

Neometals Ltd

Chris Reed, Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus

 +61 8 9322 1182

 

 

Cavendish Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

RBC Capital Markets - Joint Broker

+44 (0)20 7653 4000

Paul Betts

Jamil Miah

Camarco PR

+ 44 (0)203 757 4980

Gordon Poole

Emily Hall

Lily Pettifar

 

 

About Neometals

Neometals has developed and is commercialising three environmentally-friendly processing technologies that produce critical and strategic battery materials at lowest quartile costs with minimal carbon footprint.

 

Through strong industry partnerships, Neometals is demonstrating the economic and environmental benefits of sustainably producing of lithium, nickel, cobalt and vanadium from lithium-ion battery recycling and steel waste recovery. Reducing the reliance on traditional mine-based supply chains and creating more resilient, circular supply chains to support the energy transition.

 

The Company's three core business units are exploiting the technologies under principal, joint venture and licensing business models:

 

· Lithium-ion Battery ("LIB") Recycling (50% technology) - Commercialisation via Primobius GmbH JV (NMT 50% equity). All plants built by Primobius' co-owner (SMS group 50% equity), a 150-year old German plant builder. Providing recycling service as principal in Germany and commenced plant supply and technology licencing activities as technology partner to Mercedes-Benz. investment decision for Primobius' first commercial 50tpd plant and JV with Stelco in Canada expected end 2023;

 

· Lithium Chemicals (70% technology) - Commercialising patented ELi™ electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Co-funding Pilot Plant trials in 2023 with Demonstration Plant trials and evaluation studies in 2024 for potential 25,000tpa LiOH operation in Portugal under a 50:50 JV with Bondalti, Portugal's largest chemical company; and

 

· Vanadium Recovery (100% technology) - aiming to produce high-purity vanadium pentoxide from processing of steelmaking by-product ("Slag") at lowest-quartile operating cost. Investment decision with JV partner, Critical Metals pending on planned 9,000tpa vanadium pentoxide operation in Pori, Finland (NMT 72.5% equity). Feedstock sourced under 10-year Slag supply agreement with SSAB and product offtake agreement with Glencore. MOU with H2Green Steel for potential second, larger operation in Boden, Sweden

 

For further information visit www.neometals.com.au.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

 1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Chris Reed 

 2. 

Reason for the notification

a)

Position/status:

Chief Executive Officer 

b)

Initial notification/Amendment:

Initial Notification

 3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Neometals Ltd 

b)

LEI:

254900WO0PDVL8V1PY78 

 4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Performance Rights

 

AU000000NMT1 

b)

Nature of the transaction:

Grant of Performance Rights

 

c)

Price(s) and volume(s):

Price

Volume

Nil

571,512

d)

Aggregated information:

Aggregated volume:

Price:

N/A

 

e)

Date of the transaction:

11 September 2023

 

f)

Place of the transaction:

Off Market

 

 1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jason Carone

 2. 

Reason for the notification

a)

Position/status:

Chief Financial Officer & Company Secretary 

b)

Initial notification/Amendment:

Initial Notification

 3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Neometals Ltd 

b)

LEI:

254900WO0PDVL8V1PY78 

 4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Performance Rights

 

AU000000NMT1 

b)

Nature of the transaction:

Grant of Performance Rights

 

c)

Price(s) and volume(s):

Price

Volume

Nil

314,759

d)

Aggregated information:

Aggregated volume:

Price:

N/A

 

e)

Date of the transaction:

11 September 2023

 

f)

Place of the transaction:

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGMLLMMGFZG
Date   Source Headline
3rd Feb 20257:00 amRNSCancellation - Neometals Ltd
23rd Jan 20257:01 amRNSQuarterly Activities Report
23rd Jan 20257:01 amRNSQuarterly Cashflow
17th Jan 20257:00 amRNSCancellation of Performance Rights
20th Dec 20247:00 amRNSProposed Cancellation of Admission to AIM
6th Dec 20247:00 amRNSDirector/PDMR Dealings
22nd Nov 20249:09 amRNSResult of Annual General Meeting
22nd Nov 20247:42 amRNSChairman’s AGM 2024 Address
18th Nov 20241:14 pmRNS2024 Annual General Meeting Broadcast
12th Nov 20247:00 amRNSPositive Results from ELi™ Pilot Trial
8th Nov 20249:24 amRNSDirector / PDMR Participation in Entitlement Offer
7th Nov 202410:16 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSResults of Entitlement Offer
24th Oct 20247:01 amRNSQuarterly Activities Report
24th Oct 20247:01 amRNSQuarterly Cashflow
22nd Oct 20247:00 amRNSMercedes Benz Plant Opening
21st Oct 20247:00 amRNSNotice of Annual General Meeting
21st Oct 20247:00 amRNSEntitlement Offer Opens
18th Oct 20247:00 amRNSDirector/PDMR Dealings
14th Oct 20249:49 amRNSPosting of Annual Report
11th Oct 20247:00 amRNSA$4 Million Placement and Entitlement Offer
9th Oct 20247:00 amRNSASX Trading Halt
30th Sep 20247:50 amRNSResult of EGM
26th Sep 20248:56 amRNSAnnual Financial Report
23rd Sep 20247:00 amRNSBarrambie Gold Exploration Target
20th Sep 20247:00 amRNSAGM Update
16th Sep 20247:00 amRNSVRP receives EU supported capital injection
27th Aug 202410:02 amRNSNotice of EGM
22nd Aug 20247:00 amRNSNeometals Strategy Update
22nd Aug 20247:00 amRNSPrecious Metals Recovery Option Lapse
19th Aug 20247:00 amRNSUS$3M Placement
16th Aug 20247:00 amRNSResults of Extraordinary General Meeting
7th Aug 20247:00 amRNSCorporate Presentation
30th Jul 20247:19 amRNSQuarterly Activities Report
30th Jul 20247:15 amRNSQuarterly Cashflow
17th Jul 20248:36 amRNSNotice of Extraordinary General Meeting
11th Jul 20247:12 amRNSAppointment of Company Secretary
9th Jul 20249:59 amRNSDirector/PDMR Dealings
4th Jul 202411:59 amRNSIssue of Shares
27th Jun 202410:26 amRNSDirector Change
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.